{"created":"2021-03-01T06:27:55.997309+00:00","id":22747,"links":{},"metadata":{"_buckets":{"deposit":"9997eed5-c52e-4169-93e7-7f657fb4f375"},"_deposit":{"id":"22747","owners":[],"pid":{"revision_id":0,"type":"depid","value":"22747"},"status":"published"},"_oai":{"id":"oai:niigata-u.repo.nii.ac.jp:00022747","sets":["453:456","471:537:538:1204"]},"item_7_alternative_title_1":{"attribute_name":"その他のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"The Complications and the Quality of Life of Patients Undergoing Long-term Hemodialysis Treatment.(New Trend of Practice in Medical Specialties with Emphasis on Quality of Life)"}]},"item_7_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1989-11","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"11","bibliographicPageEnd":"884","bibliographicPageStart":"882","bibliographicVolumeNumber":"103","bibliographic_titles":[{"bibliographic_title":"新潟医学会雑誌"},{"bibliographic_title":"新潟医学会雑誌","bibliographic_titleLang":"en"}]}]},"item_7_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"The Japanese Society for Dialysis Therapy reported that a total of 80,553 had been on dialysis in our country and 13,094 (16.3%) of them for more than 10 years at the end of 1987. Among these patients 70.2% are treated with dialysis in the daytime and 26.5% at night in the clinics or hospitals, and others are on CAPD or home hemodialysis. At present 35.7% of total patients, including house wives, are almost fully rehabilitated, working at least 5 days a week. However, many of them have suffered from various complications such as renal anemia, renal osteodystrophy and β_2-microglobulin-related amyloidosis. Renal anemia is frequently sever and often impairs rehabilitation. The mechanisms underlying the anemia are complex but involve a reduction in erythropoietin production. The advent of recombinant DNA techniques has recently allowed the production of the recombinant hormone in quantities sufficient for clinical use. It is now demonstrated that replacement therapy with recombinant erythropoietin represent an efficacious and safe treatment of anemic hemodialysis patients. Among the patients treated with dialysis, those undergoing treatment of CAPD or at home are known to have a higher quality of life than center hemodialysis groups. Since most recipients of kidney transplants who maintain stable renal functions can expect an almost normal level of physical activity and enjoy their life of the pre-illness level of activity, the network for promoting kidney transplantation should be established.","subitem_description_type":"Abstract"}]},"item_7_full_name_3":{"attribute_name":"著者別名","attribute_value_mlt":[{"nameIdentifiers":[{"nameIdentifier":"137842","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Gejyo, Fumitake"}]},{"nameIdentifiers":[{"nameIdentifier":"137843","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Arakawa, Masaaki"}]}]},"item_7_publisher_7":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"新潟医学会"}]},"item_7_select_19":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_select_item":"publisher"}]},"item_7_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN00182415","subitem_source_identifier_type":"NCID"}]},"item_7_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"00290440","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"下条, 文武"}],"nameIdentifiers":[{"nameIdentifier":"137840","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"荒川, 正昭"}],"nameIdentifiers":[{"nameIdentifier":"137841","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-08-19"}],"displaytype":"detail","filename":"103(11)_882-884.pdf","filesize":[{"value":"1.1 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"103(11)_882-884.pdf","url":"https://niigata-u.repo.nii.ac.jp/record/22747/files/103(11)_882-884.pdf"},"version_id":"8147e3d2-61de-4092-bba0-43f683e4ae59"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"hemodialysis","subitem_subject_scheme":"Other"},{"subitem_subject":"renal anemia","subitem_subject_scheme":"Other"},{"subitem_subject":"erythropoietin","subitem_subject_scheme":"Other"},{"subitem_subject":"血液透析","subitem_subject_scheme":"Other"},{"subitem_subject":"腎性貧血","subitem_subject_scheme":"Other"},{"subitem_subject":"エリスロポエチン","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"2) 長期透析患者の合併症とQuality of Life(シンポジウム Quality of Life(QOL)を考慮した各科診療方針, 第444回新潟医学会)","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"2) 長期透析患者の合併症とQuality of Life(シンポジウム Quality of Life(QOL)を考慮した各科診療方針, 第444回新潟医学会)"},{"subitem_title":"2) 長期透析患者の合併症とQuality of Life(シンポジウム Quality of Life(QOL)を考慮した各科診療方針, 第444回新潟医学会)","subitem_title_language":"en"}]},"item_type_id":"7","owner":"1","path":["456","1204"],"pubdate":{"attribute_name":"公開日","attribute_value":"2016-04-13"},"publish_date":"2016-04-13","publish_status":"0","recid":"22747","relation_version_is_last":true,"title":["2) 長期透析患者の合併症とQuality of Life(シンポジウム Quality of Life(QOL)を考慮した各科診療方針, 第444回新潟医学会)"],"weko_creator_id":"1","weko_shared_id":null},"updated":"2022-12-15T03:53:04.939970+00:00"}